NeuroDex, Inc., Natick, Massachusetts, USA.
Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, USA.
J Extracell Vesicles. 2024 Nov;13(11):e70007. doi: 10.1002/jev2.70007.
Small membranous extracellular vesicles (EV) incorporate proteins and nucleic acids from the parent cell. Proteins exposed on EV surface are dictated by cellular origin and biogenesis pathway. To better understand the EV origin and function, it is important to develop methods that reveal surface protein composition of heterogeneous EV populations in culture supernatants and in biofluids. Tetraspanins CD9, CD63, and CD81 are common and abundant EV markers. However, their relative enrichment (profile) on EVs of specific cellular origins is not fully elucidated. We introduce LuminEV, a novel version of the Luminex assay for the multiplexed analysis of EV surface proteins. Optimized LuminEV reagents enable direct, specific, and sensitive measurements of EV markers in biofluids and in culture supernatants, bypassing EV isolation step. LuminEV assay for CD9, CD63, and CD81 was validated by comparing simplex and multiplex measurements, establishing linearity, spike-in recovery, inter- and intra-assay precision, and reproducibility between operators. LuminEV measurements of CD9, CD63, and CD81 in conditioned media from 15 cell lines revealed strong variations between cell types and showed high sensitivity, which enabled EV detection without prior concentration. Using tetraspanin levels as a readout, we noted suppression and induction of EV release from the cultured cells by GW6869 and monensin. Measurement of EV CD9, CD63, and CD81 in blood plasma from 70 disease-free donors showed respective abundance of 72, 16, and 12%. CD63 displayed weak, albeit significant, negative correlation with age and was slightly lower in female samples. The assay was then used to detect cell type-specific EV surface markers, including CD235a (erythrocytes), GAP43 (neurons), and CD68 (macrophages), and to detect differences in tetraspanin profiles between healthy and diseased donors. In summary, LuminEV offers robust and sensitive approach for multiplexed assessment of EV surface proteins, to facilitate the research into EV biology, biomarker, and therapeutic applications.
小膜外囊泡 (EV) 从母细胞中整合蛋白质和核酸。EV 表面暴露的蛋白质由细胞起源和生物发生途径决定。为了更好地了解 EV 的起源和功能,开发能够揭示培养上清液和生物体液中异质 EV 群体表面蛋白组成的方法非常重要。四跨膜蛋白 CD9、CD63 和 CD81 是常见且丰富的 EV 标志物。然而,它们在特定细胞起源的 EV 上的相对丰度(谱)尚未完全阐明。我们引入了 LuminEV,这是一种用于 EV 表面蛋白的多重分析的新型 Luminex 检测方法。优化后的 LuminEV 试剂能够直接、特异性和灵敏地测量生物体液和培养上清液中的 EV 标志物,无需进行 EV 分离步骤。通过比较单重和多重测量、建立线性、掺入物回收、批内和批间精密度以及操作人员之间的重现性,验证了 CD9、CD63 和 CD81 的 LuminEV 检测。从 15 种细胞系的条件培养基中测量 CD9、CD63 和 CD81,结果显示细胞类型之间存在强烈差异,并且具有高灵敏度,能够在无需预先浓缩的情况下检测 EV。使用四跨膜蛋白水平作为读出值,我们注意到 GW6869 和莫能菌素对培养细胞中 EV 释放的抑制和诱导作用。从 70 名无疾病供体的血浆中测量 EV CD9、CD63 和 CD81 的结果显示,它们的丰度分别为 72%、16%和 12%。CD63 显示出微弱但显著的负相关与年龄,并且在女性样本中略低。该检测方法随后用于检测细胞类型特异性 EV 表面标志物,包括 CD235a(红细胞)、GAP43(神经元)和 CD68(巨噬细胞),并检测健康和患病供体之间的四跨膜蛋白谱差异。总之,LuminEV 提供了一种稳健、灵敏的方法,用于多重评估 EV 表面蛋白,以促进 EV 生物学、生物标志物和治疗应用的研究。